Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3959395 | 0.98 | METAP1 (0.41) | SHBGCYP1A2METAP1SIGMAR1EPHX1 | |
| SCHEMBL22474201 | 0.98 | METAP1 (0.41) | SHBGCYP1A2METAP1SIGMAR1EPHX1 | |
| SCHEMBL21162187 | 0.94 | OPRM1 (0.43) | SHBGCYP1A2SIGMAR1EPHX1DPP4 | |
| SCHEMBL9213543 | 0.92 | OPRM1 (0.41) | SHBGCYP1A2SIGMAR1EPHX1OPRM1 | |
| SCHEMBL4871117 | 0.92 | OPRM1 (0.41) | SHBGCYP1A2SIGMAR1EPHX1OPRM1 | |
| SCHEMBL9211126 | 0.92 | OPRM1 (0.41) | SHBGCYP1A2SIGMAR1EPHX1OPRM1 | |
| SCHEMBL11296526 | 0.92 | OPRM1 (0.41) | SHBGCYP1A2SIGMAR1EPHX1OPRM1 | |
| SCHEMBL11576178 | 0.92 | OPRM1 (0.41) | SHBGCYP1A2SIGMAR1EPHX1OPRM1 | |
| SCHEMBL9208863 | 0.92 | OPRM1 (0.41) | SHBGCYP1A2SIGMAR1EPHX1OPRM1 | |
| SCHEMBL10435741 | 0.92 | OPRM1 (0.41) | SHBGCYP1A2SIGMAR1EPHX1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111868842-B | Conductive paste with stable viscosity over time | 株式会社则武 | 2021-11-19 | — | — | CN | disclosed |
| CN-111868842-A | Conductive paste with stable viscosity over time | 株式会社则武 | 2020-10-30 | — | — | CN | disclosed |
| CN-110099964-A | Polyamide resin composition for hose and hose using the same | 株式会社普利司通 | 2019-08-06 | — | — | CN | disclosed |
| CN-104853916-B | Thermoplastic resin sheet and its products formed with water repellency | 电化株式会社 | 2017-08-08 | — | — | CN | disclosed |
| EP-3121165-A1 | MONOAMINE COMPOUND, CHARGE TRANSPORT MATERIAL, COMPOSITION FOR CHARGE TRANSPORT FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING | Mitsubishi Chemical Corporation (JP) | 2017-01-25 | — | — | EP | disclosed |
| CN-104903099-B | Water-repellent, thermoplastic resin sheet, and molded article | 电化株式会社 | 2017-01-18 | — | — | CN | disclosed |
| EP-1532115-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2006-01-11 | — | — | EP | disclosed |
| EP-1532115-A2 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-05-25 | — | — | EP | disclosed |
| EP-1511492-A2 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-03-09 | — | — | EP | disclosed |
| EP-1392657-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2004-03-10 | — | — | EP | disclosed |
| EP-1392657-A2 | PROTEASE INHIBITORS | SmithKline Beecham Corporation (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2003103574-A2 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003104257-A2 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003053331-A2 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-07-03 | — | — | WO | disclosed |
| US-6057371-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2000-05-02 | — | — | US | disclosed |